| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |